APYX
ANALYST COVERAGE8 analysts
BUY
+41.2%upside to target
Buy
8100%
8 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
PRICE
Prev Close
3.79
Open
3.81
Day Range3.74 – 4.25
3.74
4.25
52W Range1.38 – 4.50
1.38
4.50
92% of range
VOLUME & SIZE
Avg Volume
165.8K
FUNDAMENTALS
P/E Ratio
-19.3x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.72
High vol
TECHNICAL
RSI (14)
52
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 96 days
Aug 25

APYX News

About

apyx medical corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. it operates in two segments, advanced energy and original equipment manufacturing (oem). the company develops j-plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. it markets and sells helium plasma technology under the renuvion brand name in the cosmetic surgery market and under the j-plasma brand name in the hospital surgical market. the company's renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the j-plasma system allows surgeons to operate in eliminating unintended tissue trauma. it also designs, develops, manufactures, and sells electrosurgical and oem generators and related accessories for medical device manufacturers. the company was formerly known as bovie medical corporation and changed

Industry
Surgical and Medical Instrument Manufacturing
CEO
Robert Gershon
Charles D. GoodwinPresident, Chief Executive Officer & Director
Matthew C. HillChief Financial Officer, Treasurer & Secretary
Moshe CitronowiczSenior Vice President
Shawn D. RomanChief Operating Officer
Dolores CataniaChief of Confidence